ArticleJACS Au2026
Microsecond Dynamics of the Pyrophosphate Ion Release in SARS-CoV‑2 RNA Polymerase.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA-dependent RNA polymerase (RdRp) is the central molecular machine for viral replication and transcription. It catalyzes the nucleotide addition reaction, in which the release of the pyrophosphate ion (PPi) is a critical step in the resumption of the catalysis cycle. However, the precise mechanism by which PPi is released in the viral RdRp remains elusive, thereby impeding a comprehensive comprehension of the transcription and replication mechanisms of RdRp. In this study, we elucidated the molecular mechanism of PPi release in SARS-CoV-2 through the construction of a tailor-made Markov state model informed by extensive molecular dynamics simulations. We identified three metastable states, which demonstrate the stepwise release of PPi over a timescale of 3.6 μs. Additionally, we discovered that four highly conserved and positively charged residues, K551, R553, R555, and K798, can collectively mediate the release of PPi, suggesting their typical roles in the transcription and replication of coronaviruses. A two-step NTP incorporation assay and a PPi-mediated cleavage assay (pyrophosphorolysis) were developed and performed, validating their impact on PPi release by assessing both forward nucleotide incorporation efficiency and reverse RNA cleavage efficiency under exogenous PPi treatment. Further comparisons with the mechanisms utilized by other polymerases indicate that our study reveals a distinctive model of PPi release. In summary, our investigation contributes to advancing our understanding of the transcription and replication mechanism of viral RdRps by offering a glimpse into the dynamics of PPi release in SARS-CoV-2 RdRp.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.